Targeting EZH2 in Cancer: Mechanisms, Pathways, and Therapeutic Potential
Maria Saveria Gilardini Montani, Rossella Benedetti, Mara Cirone · 2024
Read Targeting EZH2 in Cancer: Mechanisms, Pathways, and Therapeutic Potential by Maria Saveria Gilardini Montani, Rossella Benedetti, Mara Cirone (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11678268.txt.
Description
Maria Gilardini Montani, Rossella Benedetti, and Mara Cirone review, in 2024, a gene-silencing enzyme as a cancer drug target. The enzyme, EZH2, tags DNA-packaging proteins to switch genes off and steers cell division, specialization, and death. In many cancers it is overactive, silencing tumor suppressors and helping tumors hide from the immune system.
The review walks through how the enzyme controls suppressor genes and growth drivers, how it shapes anti-cancer immunity, and how chemical modifications tune its own stability. Strategies to block it, from direct inhibitors to combination approaches, close the survey. The authors weigh its therapeutic promise across cancer types.
Catalog record
| CREATOR | Maria Saveria Gilardini Montani, Rossella Benedetti, Mara Cirone |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 24 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |